Table 1.
Patient clinical characteristics.
Clinical characteristics | |
---|---|
Age (years) | 70 ± 11 |
Male gender | 57 (58.2%) |
Height (cm) | 159.3 ± 8.6 |
Body weight (kg) | 59.6 ± 11.9 |
Body mass index | 23.5 ± 4.4 |
SBP (mmHg) | 138.2 ± 23 |
DBP (mmHg) | 78.6 ± 14.8 |
Heart rate (beats/min) | 76.5 ± 15.3 |
WBC (×102/μL) | 61.6 ± 17.9 |
Neut (%) | 63.2 ± 9.5 |
Lymph (%) | 26.6 ± 8.9 |
Mono (%) | 6.0 ± 1.8 |
Eosino (%) | 3.6 ± 2.7 |
Baso (%) | 0.6 ± 0.4 |
Neutrophil/lymphocyte | 2.8 ± 1.5 |
Log-NLR | 0.4 ± 0.2 |
Plt (×104/μL) | 20.3 ± 5.5 |
RBC (×104/μL) | 428 ± 67 |
Hb (g/dL) | 13.0 ± 2.1 |
MCV (fL) | 92.4 ± 4.9 |
RDW-CV | 13.8 ± 1.1 |
eGFR (mL/min/1.73m2) | 60.4 ± 27.1 |
Comorbidity | |
Hypertension | 74 (75.5%) |
Diabetes mellitus | 43 (43.9%) |
Dyslipidemia | 47 (48.0%) |
Heart failure | 18 (18.4%) |
Angina pectoris | 25 (25.5%) |
Old myocardial infarction | 22 (22.4%) |
History of PCI | 20 (20.4%) |
Cerebral infarction | 13 (13.3%) |
Cerebral hemorrhage | 2 (2.0%) |
Peripheral artery disease | 24 (24.5%) |
History of gastroduodenal ulcer | 7 (7.1%) |
Reflux esophagitis | 9 (9.2%) |
Medication | |
Antiplatelet agents | 52 (53.1%) |
ARB | 51 (52.0%) |
Calcium channel blockers | 46 (46.9%) |
β-blockers | 38 (38.8%) |
Diuretic agents | 32 (32.7%) |
Statins | 30 (30.6%) |
PPI | 30 (30.6%) |
Oral hypoglycemic agents | 19 (19.4%) |
H2-blockers | 15 (15.3%) |
Warfarin | 13 (13.3%) |
ACEI | 11 (11.2%) |
Uric acid-lowering agents | 7 (7.1%) |
Insulin | 3 (3.1%) |
Data given as mean ± SD or n (%). ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate; H2-blocker: histamine type 2 receptor blocker; Hb: hemoglobin; Ht: hematocrit; MCV: mean corpuscular volume; log-NLR: log-transformed neutrophil/lymphocyte ratio; PCI: percutaneous coronary intervention; Plt: platelet; PPI: proton pump inhibitor; RBC: red blood cells; RDW-CV: coefficient of variation of red cell distribution width; SBP: systolic blood pressure; WBC: white blood cells.